Cytokinetics, Inc. (CYTK)
69.01
-2.47
(-3.46%)
USD |
NASDAQ |
Jun 08, 15:17
Cytokinetics Shareholders Equity (Quarterly) : -826.57M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 491.41M |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| BioMarin Pharmaceutical, Inc. | 6.212B |
| Regeneron Pharmaceuticals, Inc. | 31.42B |
| BridgeBio Pharma, Inc. | -2.278B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.273B |
| Total Liabilities (Quarterly) | 2.100B |
| Debt to Equity Ratio | -1.559 |
| Current Ratio | 4.214 |
| Net Debt Paydown Yield | -1.22% |